Dr. Roach is a Professor of Radiation Oncology and Urology in the Department of Radiation Oncology at the University of California San Francisco. He is recognized as a major authority on the treatment of localized prostate cancer. He earned his MD from Stanford University, completed a fellowship in Medical Oncology at UCSF and then returned to Stanford University to complete his residency in Radiation Oncology. His research interests involve the application of image-guided intensity-modulated radiation therapy (IMRT) and Brachytherapy and defining the optimal imaging modalities and criteria for selecting specific targets for radiation, while minimizing treatment related complications. He has helped to pioneer the use of endorectal Magnetic Spectroscopy imaging as a means of monitoring prostate cancer outcomes. Dr. Roach was a leader in establishing the American College of Radiology (ACR) Appropriateness Criteria Guidelines for defining how men in this should be treated with radiotherapy from 1996 through 2006. He also served on the NCI Intensity Modulated Radiotherapy Working Group to describing criteria the use of this new technology and currently serves on the National Comprehensive Cancer Guidelines Committee for Prostate Cancer. He has been the recipient of numerous awards, such as the American Cancer Society Career Development Award and the UCSF Health Net Wellness Award. He is a Fellow of the ACR and ASTRO. Dr. Roach has co-authored more than 200 peer-reviewed journal articles, book chapters and/or editorials. He has served on numerous the editorial boards and was appointed (2013) by President Obama to serve on a 6-year term on the National Cancer Advisory Board (NCAB) which is involved in defining the research agenda for our nation.